Combining Clinical and Biological Data to Predict Progressive Pulmonary Fibrosis in Patients With Systemic Sclerosis Despite Immunomodulatory Therapy

OBJECTIVE: Progressive pulmonary fibrosis (PPF) is the leading cause of death in systemic sclerosis (SSc). This study aimed to develop a clinical prediction nomogram using clinical and biological data to assess risk of PPF among patients receiving treatment of SSc‐related interstitial lung disease (...

Descripción completa

Detalles Bibliográficos
Autores principales: Volkmann, Elizabeth R., Wilhalme, Holly, Assassi, Shervin, Kim, Grace Hyun J., Goldin, Jonathan, Kuwana, Masataka, Tashkin, Donald P., Roth, Michael D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570669/
https://www.ncbi.nlm.nih.gov/pubmed/37592449
http://dx.doi.org/10.1002/acr2.11598

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570669/
https://www.ncbi.nlm.nih.gov/pubmed/37592449
http://dx.doi.org/10.1002/acr2.11598

Ejemplares similares